% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

  • jonaustin1481 jonaustin1481 May 7, 2009 4:08 PM Flag

    Starting to unwind position

    It just got to be too ridiculous for me, downright embarrassed holding this one for so long. It's a travesty for the patients most of all. In fact, it has me questioning the actual viability of the drug. If it were as great as its been presented, then why isn't it available to patients? It should have been snapped up at favorable terms months ago. It's an either/or situation at this point as I see it:

    a - The drug is flawed in some way and not widely accepted, not effective, and/or not commercially attractive to a partner.


    b - If none of the above apply, then the management are completely inept and derelict in their duty to patients and shareholders alike.

    So which is it? There are no other choices!

    Further, I believe it would be absolute insanity to hold going into the SH meeting and another massive dilution.

    I cannot recall ever feeling more satisfaction at selling shares a company than I have selling epicrapt (EPCT) today.

    I hope to be 80% sold sometime next week depending on the daily volume. (The volume is so low you gotta sell in small lots.)

    I will keep a tiny position just for grins, but I don't expect great things, though I once did, had these no-brain idiots delivered as promised.

    Best of luck

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.34-0.03(-8.13%)Jul 22 3:59 PMEDT